Clinical Trial: Interaction of MTNR1B Genotype and Type of Breakfast (protein-enriched V Carbohydrate-rich) on Postprandial Glucose Response.

U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06821620) titled 'Interaction of MTNR1B Genotype and Type of Breakfast (protein-enriched V Carbohydrate-rich) on Postprandial Glucose Response.' on Aug. 01, 2024.

Brief Summary: The risk version of the MTNR1B gene (which codes for a melatonin receptor) has been associated with type II diabetes (T2D) and associated physiological markers. People with the risk version of the gene have reduced secretion of insulin when melatonin levels are high (between evening and morning) and impaired glucose tolerance when they eat late. Previous research suggests eating a protein enriched breakfast can improve glucose response. Therefore, the present study will inves...